Results 71 to 80 of about 10,684 (213)
Mitochondrial Abnormalities of T Lymphocytes in Patients With Maintenance Hemodialysis
Immunity, Inflammation and Disease, Volume 14, Issue 3, March 2026.ABSTRACT Objective To investigate the characteristics of T lymphocyte subsets and mitochondrial function in hemodialysis patients and to explore the effect of hemodialysis on these parameters. Methods Patients with end‐stage renal disease (ESRD) from July 2023 to June 2024, who underwent mitochondrial function detection of T lymphocyte subsets, were ...
Chunlei Luo +6 more
wiley +1 more source
Hemofiltration for neuroprotection in acute ischemic stroke: A prospective, pilot study
, 2019 Background: Hemofiltration reduces blood levels of cytokines, glutamate, and other substances that increase the risk of stroke-associated neurodegeneration.
Bilotta, Federico +3 more
core +1 more source
Individualized drug dosage in patients treated with continuous hemofiltration [PDF]
, 1999 Individualized drug dosage in patients treated with continuous hemofiltration.BackgroundSubtherapeutic drug dosing may be even more dangerous than overdosage, especially for intensive care patients requiring hemofiltration.ProposalAccording to Dettli's ...
Czock, David +5 more
core +1 more source
Small Science, Volume 6, Issue 3, March 2026.Current treatments for severe lupus nephritis are limited by side effects due to poor drug targeting. This review explores how smart nanomaterials—like liposomes and biomimetic carriers—can precisely deliver drugs to overactive immune cells and the kidneys. These nanotherapeutics enhance efficacy, reduce toxicity, and enable combination strategies. The
Cheng Zhou +6 more
wiley +1 more source
Hemofiltration in sepsis: Where do we go from here?
, 2000 Hemofiltration as an adjunct to therapy for sepsis is now 10 years old. Despite early successes and significant theoretical advantages, the treatment remains experimental.
Kellum, JA, Bellomo, R
core +1 more source
Hemofiltration treatment for sepsis: Is it time for controlled trials? [PDF]
, 1999 Hemofiltration treatment for sepsis: Is it time for controlled trials? While the use of hemofiltration to treat septic shock has potential benefits, the existing studies are difficult to compare because of their variety of inclusion criteria. The concept
Rogiers, Peter
core +1 more source
Journal of Medical Case Reports, 2012 Introduction Fulminant cardiopulmonary failure is a severe complication of hand, foot and mouth diseases due to enterovirus 71 infection, with a high mortality rate. The treatment is mainly supportive with aggressive cardiopulmonary resuscitation.
Phan Phuc +6 more
doaj +1 more source
Hemofiltration: Determinants of Drug Loss and Concentration
, 2023 Ultrafiltration has proven to be an effective method of reducing post-cardiopulmonary bypass edema and the inflammatory response associated with activation of the complement cascade.
Alexander Clar, Douglas F. Larson
core +1 more source
Continuous Venovenous Hemofiltration Without Anticoagulation
, 2004 Continuous Venovenous Hemofiltration Without ...
H Morimatsu (13319397) +4 more
core
Hemofiltration in patients with severe acute pancreatitis (review)
, 2020 Questions regarding the application of extracorporeal detoxification to patients with severe acute pancreatitis have been considered. Hemodialysis, the historically first method of extracorporeal detoxification for such patients, has been also described ...
Boyarinov G.
core